Macular degeneration trials in Slovakia

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

  Where

  Banska Bystrica, Bratislava, Nitra, Petrzalka, Poprad, Stare Mesto, Trebišov, Trenčín, Žilina

  Age

  50 years and over

  People

  304 worldwide

  Run by

  Amgen

  See details and how to joinNCT07614776 · EU 2025-523500-72-00
• Phase 3Not yet taking people in Slovakia
  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  Where

  Bratislava, Trenčín, Žilina

  Age

  50 years and over

  People

  561 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07007065 · EU 2024-512298-28-00
• Phase 2/3Taking people
  A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)

  Where

  Petrzalka, Trebišov, Trenčín, Žilina

  Age

  18 years and over

  People

  250 worldwide

  Run by

  Eyebiotech Limited

  See details and how to join2025-524894-17-00